Almkvist O - Search Results

1

Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.

Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A. Carter SF, et al. Among authors: almkvist o. J Nucl Med. 2012 Jan;53(1):37-46. doi: 10.2967/jnumed.110.087031. J Nucl Med. 2012. PMID: 22213821 Free article.

2

Skin vessel reactivity is impaired in Alzheimer's disease.

Algotsson A, Nordberg A, Almkvist O, Winblad B. Algotsson A, et al. Among authors: almkvist o. Neurobiol Aging. 1995 Jul-Aug;16(4):577-82. doi: 10.1016/0197-4580(95)00077-r. Neurobiol Aging. 1995. PMID: 8544908

3

Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease.

Jelic V, Dierks T, Amberla K, Almkvist O, Winblad B, Nordberg A. Jelic V, et al. Among authors: almkvist o. Neurosci Lett. 1998 Sep 25;254(2):85-8. doi: 10.1016/s0304-3940(98)00669-7. Neurosci Lett. 1998. PMID: 9779926 Clinical Trial.

4

Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease.

Bäckman L, Andersson JL, Nyberg L, Winblad B, Nordberg A, Almkvist O. Bäckman L, et al. Among authors: almkvist o. Neurology. 1999 Jun 10;52(9):1861-70. doi: 10.1212/wnl.52.9.1861. Neurology. 1999. PMID: 10371535

5

Impairment of neocortical metabolism predicts progression in Alzheimer's disease.

Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, Jelic V, Almkvist O, Collette F, Alberoni M, Kennedy A, Hasselbalch S, Fazio F, Heiss WD. Herholz K, et al. Among authors: almkvist o. Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):494-504. doi: 10.1159/000017196. Dement Geriatr Cogn Disord. 1999. PMID: 10559566 Clinical Trial.

6

A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation.

Wahlund LO, Basun H, Almkvist O, Julin P, Axelman K, Shigeta M, Jelic V, Nordberg A, Lannfelt L. Wahlund LO, et al. Among authors: almkvist o. Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):526-33. doi: 10.1159/000017200. Dement Geriatr Cogn Disord. 1999. PMID: 10559570 Clinical Trial.

7

Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease.

Jelic V, Johansson SE, Almkvist O, Shigeta M, Julin P, Nordberg A, Winblad B, Wahlund LO. Jelic V, et al. Among authors: almkvist o. Neurobiol Aging. 2000 Jul-Aug;21(4):533-40. doi: 10.1016/s0197-4580(00)00153-6. Neurobiol Aging. 2000. PMID: 10924766

8

Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients.

Almkvist O, Jelic V, Amberla K, Hellström-Lindahl E, Meurling L, Nordberg A. Almkvist O, et al. Dement Geriatr Cogn Disord. 2001 Jan-Feb;12(1):22-32. doi: 10.1159/000051232. Dement Geriatr Cogn Disord. 2001. PMID: 11125238 Clinical Trial.

9

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment.

Arnáiz E, Jelic V, Almkvist O, Wahlund LO, Winblad B, Valind S, Nordberg A. Arnáiz E, et al. Among authors: almkvist o. Neuroreport. 2001 Mar 26;12(4):851-5. doi: 10.1097/00001756-200103260-00045. Neuroreport. 2001. PMID: 11277595

10

Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.

Darreh-Shori T, Almkvist O, Guan ZZ, Garlind A, Strandberg B, Svensson AL, Soreq H, Hellström-Lindahl E, Nordberg A. Darreh-Shori T, et al. Among authors: almkvist o. Neurology. 2002 Aug 27;59(4):563-72. doi: 10.1212/wnl.59.4.563. Neurology. 2002. PMID: 12196650 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters